Iloperidone results (p-values) by trial, dose group, and diagnosis.

Figshare2015-12-02 更新2026-04-29 收录

数据链接：

https://figshare.com/articles/dataset/_Iloperidone_results_p_values_by_trial_dose_group_and_diagnosis_/335476 数据链接链接失效反馈

官方服务：

资源简介：

Statistically significant p-values (p-values from journal articles; all others are from the FDA review of iloperidone. See text for details.

创建时间：

2015-12-02

Dataset from A Multi Centre, Double-Blind, Double-Dummy, Placebo-Controlled, Randomised, Adaptive, Dose-Range Study To Evaluate the Safety and Efficacy of SB-773812 Administered Once Daily for 12 Weeks in Adults With Schizophrenia

精神药物临床试验

抗精神病药剂量范围研究

This is a two part study designed to evaluate the safety and efficacy of SB-773812 in the treatment of acute schizophrenia. Subjects with acute schizophrenia will be randomized in an adaptive design s

NIAID Data Ecosystem30

Dataset from An Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled, Active-referenced (Paroxetine), Fixed-dose Study on the Efficacy of Vortioxetine on Cognitive Dysfunction in Working Patients With Major Depressive Disorder

抑郁症认知功能

精神药物临床试验

To assess the efficacy of acute treatment with 10 mg/day vortioxetine versus placebo on cognitive performance (focusing on the aspect concerning speed of processing, executive functioning, attention)

NIAID Data Ecosystem10

A Randomized, Double-Blind, Placebo-Controlled, Flexible Dosage Trial to Evaluate the Efficacy and Tolerability of Paroxetine CR in Patients with Generalized Anxiety Disorder (GAD)

精神药物临床试验

广泛性焦虑障碍

Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promot

DataCite Commons2025-04-01 更新00

Comparisons of Exclusion Rates between Adults with current D(m), Pure MDD, and D(BP2) in Typical Clinical Trials of Treatments for DSM-IV MDD by Traditional Eligibility Criteria.

精神药物临床试验

抑郁症亚型研究

aDerived from Zimmerman et al. [29] (method described in the paper).bIncludes panic disorder, agoraphobia, social anxiety disorder, specific phobia, and generalized anxiety disorder.Odds ratios were e

Figshare2015-12-02 更新10

Effect sizes of the results of VFSS after safinamide treatment.

帕金森病吞咽评估

药物疗效统计

Effect sizes of the results of VFSS after safinamide treatment.

Figshare2023-05-25 更新10